In a world where innovative therapies are entering the market at an unprecedented pace, stakeholders need quick access to reliable information to help ensure the health care system is working as it should. They need fresh perspectives and data to keep up with how tools and techniques are working to help maintain balance in the managed care ecosystem. Enter AMCP’s recently released 2024 Access, Affordability, and Outcomes (AAO) report, which serves as a useful guide on how managed care pharmacy tools drive impact for patients.

More than 2,500 managed care pharmacy professionals from health plans, PBMs, pharmaceutical manufacturers, and other managed care organizations convened in Las Vegas, NV from Oct. 14–17 for AMCP Nexus 2024, the industry’s premier fall meeting. Attendees connected with like-minded professionals, discussed the key trends impacting their work, and expanded their perspectives through leading-edge education sessions.

Welcome to the latest update from Professional Affairs! This fall has been packed with major developments—from the release of Maximum Fair Prices for Medicare drugs to continued government focus of pharmacy benefit managers and much more.

View an executive summary of the key findings from the AMCP 2024 Access, Affordability and Outcomes: The Value of Managed Care Pharmacy report.

Wet age-related macular degeneration is a condition that can lead to significant vision loss. It is treated with regular injections, which often work well at preventing vision loss but are a burden to patients with the condition.